Psychedelics Business

News

atai Acquires Firm Developing Schizophrenia Treatment, Plans IPO

01/21/2021

atai Life Sciences, a clinical-stage biopharmaceutical firm backed by Peter Thiel and other investors, recently acquired a majority stake in Recognify Life Sciences. Recognify is developing a treatment for cognitive impairment associated...

atai Life Sciences, a...

01/21/2021

Behavioral Healthcare Executive

News

Mind Cure to Acquire Ownership Interest in Psychedelic-Assisted Therapy Treatment Center

01/13/2021

Mind Cure Health, a Vancouver, British Columbia-based mental health firm, announced this week that it has signed a letter of intent to acquire an ownership interest in ATMA Journey Centers, a Calgary, Alberta-based treatment center that...

Mind Cure Health, a Vancouver,...

01/13/2021

Behavioral Healthcare Executive

News

COMPASS Pathways, Sheppard Pratt Collaborate on Research Facility

01/12/2021

London-based COMPASS Pathways and the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore announced that the two organizations are collaborating on a “Centre of Excellence” that will serve as a research facility...

London-based COMPASS Pathways...

01/12/2021

Behavioral Healthcare Executive

News

Novamind Begins Trading Shares on Canadian Exchange

01/05/2021

Novamind, a Toronto-based mental health company that specializes in psychedelic-assisted therapy, announced that common shares of the company were to begin trading on the Canadian Securities Exchange on Tuesday.

Novamind, a Toronto-based mental...

01/05/2021

Behavioral Healthcare Executive

Browse Our Other Brands

Psychedelics Business

Browse Our Other Brands

Specialties

Events

Year Round Education

HMP Global Products